
Apollo Hospitals Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Apollo Hospitals Q1 Results FY27: Uniresearch projects Revenue Rs 6,870 Cr | PAT Rs 556 Cr (29-analyst consensus). Q4 FY26: Rev Rs 6,606 Cr | PAT Rs 551 Cr.
Updated: 25 Jun 2026 • 11:10 am
Posted by:

The Apollo Hospitals Q1 Results FY27 outlook is anchored on Q4 FY26 verified actuals and Uniresearch analysis applying the 29-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 6,870 Cr (+17.6% YoY) and PAT Rs 556 Cr (+26.0% YoY). Prepared by Ankit Jaiswal.
Click Here – Get Free Investment Predictions
Apollo Hospitals Q1 Results FY27 – Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 Results FY27 Uniresearch Prediction | YoY Change | Source |
|---|---|---|---|---|
| Apollo Hospitals Revenue (Rs Cr) | 5,842 | 6,870 | +17.6% | Uniresearch | 29-analyst consensus applied to Q1 FY26 verified actual |
| PAT (Rs Cr) | 441 | 556 | +26.0% | Uniresearch | 29-analyst consensus applied to Q1 FY26 verified actual |
| Avg Analyst Target | Rs 9,208 | 12-month view | – | Analyst consensus (29 analysts) |
Predictions apply 29-analyst FY27 consensus (Rev +17.6%, PAT +26.0%) to Q1 FY26 verified actuals. Not guaranteed outcomes.
Apollo Hospitals Q4 FY26 Key Metrics – Baseline for Apollo Hospitals Q1 Results FY27
| Metric | Q4 FY26 Actual | YoY Change | Source |
|---|---|---|---|
| Revenue (Rs Cr) | 6,606 | +18.1% YoY | Consolidated quarterly financial data |
| PAT (Rs Cr) | 551 | +33.1% YoY | Consolidated quarterly financial data |
What Analysts Are Saying About Apollo Hospitals Q1 Results FY27
Across 29 analysts covering Apollo Hospitals, the FY27 consensus projects revenue growth of +17.6% and profit growth of +26.0%, with an average 12-month price target of Rs 9,208. The Q1 Results FY27 prediction reflects this consensus applied to verified Q1 FY26 actuals.
Key Watchpoints for Apollo Hospitals
Revenue Delivery vs Consensus for Apollo Hospitals
The primary watchpoint is whether Revenue in Q1 Results FY27 delivers in line with the Uniresearch projection of Rs 6,870 Cr (+17.6% consensus growth). Q1 FY26 base was Rs 5,842 Cr.
PAT Performance in Q1 Results FY27
The PAT watchpoint is whether Apollo Hospitals achieves Rs 556 Cr (+26.0% growth from Q1 FY26 base of Rs 441 Cr). Q4 FY26 PAT was Rs 551 Cr.
Risks to the Apollo Hospitals Prediction
Below-Consensus Revenue Growth
If Revenue comes in below the +17.6% consensus, actual revenue would fall short of Rs 6,870 Cr.
PAT Pressure in Q1 Results FY27
The PAT prediction of Rs 556 Cr could be impacted by cost escalation not factored into the 29-analyst consensus of +26.0%.
Conclusion: Apollo Hospitals
The Apollo Hospitals Uniresearch prediction of Revenue Rs 6,870 Cr and PAT Rs 556 Cr is derived from the 29-analyst consensus FY27 growth rates applied to verified Q1 FY26 actuals. When Q1 Results FY27 are declared, investors can benchmark actual performance against this consensus prediction. Track live updates on Univest.
Track Apollo Hospitals Live on the Univest Screener
Download the Univest iOS App or Univest Android App for live Q1 Results FY27 alerts.
Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals – these are analyst consensus projections and are not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.
Frequently Asked Questions on Apollo Hospitals
What is Uniresearch’s PAT prediction for Apollo Hospitals Q1 Results FY27?
Ans. Uniresearch projects Apollo Hospitals Q1 PAT at Rs 556 Cr, applying 29-analyst FY27 profit growth consensus of +26.0% to Q1 FY26 verified PAT of Rs 441 Cr.
What is the Revenue prediction for Apollo Hospitals Q1 Results FY27?
Ans. Apollo Hospitals Q1 Revenue is projected at Rs 6,870 Cr, applying +17.6% FY27 revenue consensus to verified Q1 FY26 base.
What were Apollo Hospitals Q1 Results FY27?
Ans. Q4 FY26 consolidated Revenue was Rs 6,606 Cr (+18.1% YoY) and PAT was Rs 551 Cr (+33.1% YoY).
Does the Apollo Hospitals Q1 Results FY27?
Ans. No. All predictions in this article are derived from the 29-analyst consensus applied to verified Q1 FY26 actuals.
What is the analyst target price mentioned in the Apollo Hospitals Q1 Results FY27?
Ans. The 29-analyst consensus gives an average 12-month price target of Rs 9,208 for Apollo Hospitals.
What are the risks to the Apollo Hospitals Q1 Results FY27?
Ans. Risks include below-consensus revenue growth (target: +17.6%) and unexpected cost pressures impacting the +26.0% PAT consensus.
What is the Q1 FY26 base for the Apollo Hospitals Q1 Results FY27?
Ans. Q1 FY26 consolidated Revenue was Rs 5,842 Cr and PAT was Rs 441 Cr. These form the base for the Apollo Hospitals Q1 prediction.
Recent Articles

JSW Steel Q1 Results FY27: Uniresearch Prediction and Analysis
25 June 2026

Va Tech Wabag Latest News: VA Tech Wabag Scales 52-Week High of Rs 2,128.60 Backed by Strong Fundamentals
25 June 2026

Siemens India Q1 Results FY27: Uniresearch Prediction and Analysis
25 June 2026

Can Fin Homes Q1 Results FY27: Uniresearch Prediction and Analysis
25 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
JSW Steel Q1 Results FY27: Uniresearch Prediction and Analysis
Va Tech Wabag Latest News: VA Tech Wabag Scales 52-Week High of Rs 2,128.60 Backed by Strong Fundamentals
Siemens India Q1 Results FY27: Uniresearch Prediction and Analysis
Can Fin Homes Q1 Results FY27: Uniresearch Prediction and Analysis
PG Electroplast Q1 Results FY27: Uniresearch Prediction and Analysis
Popular this week
JSW Steel Q1 Results FY27: Uniresearch Prediction and Analysis
Va Tech Wabag Latest News: VA Tech Wabag Scales 52-Week High of Rs 2,128.60 Backed by Strong Fundamentals
Siemens India Q1 Results FY27: Uniresearch Prediction and Analysis
Can Fin Homes Q1 Results FY27: Uniresearch Prediction and Analysis
PG Electroplast Q1 Results FY27: Uniresearch Prediction and Analysis

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





